QCM
NVAX icon

Quantinno Capital Management’s Novavax NVAX Stock Holding History

Quantinno Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Buy
236,909
+201,550
+570% +$1.81M ﹤0.01% 1888
2026
Q1 		$288K Buy
35,359
+12,304
+53% +$112K ﹤0.01% 3053
2025
Q4 		$155K Sell
23,055
-3,412
-13% -$25.7K ﹤0.01% 3089
2025
Q3 		$229K Buy
26,467
+8,869
+50% +$69K ﹤0.01% 2666
2025
Q2 		$111K Buy
+17,598
New +$117K ﹤0.01% 2494

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Quantinno Capital Management's NVAX Position: Q2 2026 in Review

Quantinno Capital Management increased its Novavax (NVAX) stake by 570% in Q2 2026, buying an estimated $1.81M and bringing the position to 236,909 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1888.

Quantinno Capital Management first reported a position in NVAX in Q2 2025 and has held it in 5 quarters since. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Quantinno Capital Management held 236,909 shares of Novavax worth $2.23M as of Q2 2026.
  • Quantinno Capital Management bought 201,550 Novavax shares in Q2 2026, an estimated $1.81M.
  • Novavax made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1888 holding.
  • Quantinno Capital Management first reported a position in Novavax in Q2 2025 and has held it in 5 quarters since.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.